Business Description
Valbiotis SA
ISIN : FR0013254851
Compare
Compare
Traded in other countries / regions
ALVAL.France8JD.Germany IPO Date
2017-06-07Description
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.04 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | -0.84 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.86 | |||||
| Beneish M-Score | 1.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.9 | |||||
| 3-Year EBITDA Growth Rate | -17.4 | |||||
| 3-Year EPS without NRI Growth Rate | -4.6 | |||||
| 3-Year Book Growth Rate | 10.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 27.91 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.53 | |||||
| 9-Day RSI | 58.08 | |||||
| 14-Day RSI | 56.7 | |||||
| 6-1 Month Momentum % | -6.09 | |||||
| 12-1 Month Momentum % | -73.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.89 | |||||
| Quick Ratio | 4.54 | |||||
| Cash Ratio | 3.86 | |||||
| Days Inventory | 142.52 | |||||
| Days Sales Outstanding | 1061.52 | |||||
| Days Payable | 174.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.1 | |||||
| Shareholder Yield % | 2.14 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -477.8 | |||||
| Operating Margin % | -1720.68 | |||||
| Net Margin % | -1697.15 | |||||
| FCF Margin % | -1450.85 | |||||
| ROE % | -55.77 | |||||
| ROA % | -31.9 | |||||
| ROIC % | -107.15 | |||||
| ROC (Joel Greenblatt) % | -384.44 | |||||
| ROCE % | -42.05 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 41.52 | |||||
| PB Ratio | 1.28 | |||||
| Price-to-Tangible-Book | 1.39 | |||||
| EV-to-EBIT | -1.07 | |||||
| EV-to-EBITDA | -1.29 | |||||
| EV-to-Revenue | 17.86 | |||||
| EV-to-FCF | -1.2 | |||||
| Price-to-Net-Current-Asset-Value | 1.51 | |||||
| Price-to-Net-Cash | 2.31 | |||||
| Earnings Yield (Greenblatt) % | -93.57 | |||||
| FCF Yield % | -35.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valbiotis SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.527 | ||
| EPS (TTM) (€) | -0.65 | ||
| Beta | -0.02 | ||
| Volatility % | 88.52 | ||
| 14-Day RSI | 56.7 | ||
| 14-Day ATR (€) | 0.075916 | ||
| 20-Day SMA (€) | 1.3336 | ||
| 12-1 Month Momentum % | -73.58 | ||
| 52-Week Range (€) | 1.07 - 5.3 | ||
| Shares Outstanding (Mil) | 15.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valbiotis SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valbiotis SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valbiotis SA Frequently Asked Questions
What is Valbiotis SA(XPAR:ALVAL)'s stock price today?
The current price of XPAR:ALVAL is €1.39. The 52 week high of XPAR:ALVAL is €5.30 and 52 week low is €1.07.
When is next earnings date of Valbiotis SA(XPAR:ALVAL)?
The next earnings date of Valbiotis SA(XPAR:ALVAL) is .
Does Valbiotis SA(XPAR:ALVAL) pay dividends? If so, how much?
Valbiotis SA(XPAR:ALVAL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers